Earlier this month, Prana Thoracic (#LSIAlumni) announced the final close of its Series A extension round raising an additional $3 million in an oversubscribed funding round, bringing the total funding to $9 million. The round was supported by new #investors cultivate(MD),

We're looking forward to Pedro's presentation this September! Link in bio to join us in Portugal to connect with leading #Medtech innovators.

We’re excited to announce a new Fireside Chat at LSI Europe ‘24: "SIA Story: The Good, the Bad, and the Ugly of M&A." This session will serve as a case study on the acquisition of SIA by Integra LifeSciences, offering an inside look at the real-life experiences of those who were

We're just 4 weeks away from #LSIEurope24, but the buzz is already building amongst leading #investors, #strategics, and #innovators for #LSIUSA25 in #DanaPoint, #California. After reviewing applications from global leaders working to build breakthrough #Medtech and #Healthtech

#CairnSurgical (#LSIAlumni) closed a $4.5 million Series A2 financing, led by Morningside Ventures. The company will use these new funds to complete the currently-enrolling U.S. pivotal trial of its Breast Cancer Locator (BCL™) System and implement a limited commercial launch

#Innoventric is at the forefront of addressing tricuspid regurgitation (TR), a condition affecting over 4.5 million people in the U.S. and Europe. Tricuspid regurgitation (TR) is a condition where blood flows back from the right ventricle into the right atrium, causing venous

#Medtech startups should prioritize early patent filing to attract investors. However, IP is just one part of a broader strategy including regulatory approvals and operational capabilities. For more on IP in Medtech ventures, see the full LSI USA '24 panel discussion with experts